FDA Issues Warning Letters to Two Chinese Firms Regarding Data Quality and Integrity Concerns, Violative Lab Practices

Estimated reading time: 1 minutes

• About The Author

FDA issued warning letters to two Chinese nonclinical testing laboratories, citing both for laboratory oversight failures and animal care violations that raise concerns about the quality and integrity of data generated by the labs.

About The Author

See author's posts

Trending

Android malware steals payment card data using previously unseen technique